CombiGene AB (COJ0) Stock Statistics & Valuation Metrics

CombiGene AB has a market cap or net worth of €4.21M. The enterprise value is ―.

CombiGene AB has 19,801,197 shares outstanding. The number of shares has decreased by -2.65% in one year.

CombiGene AB’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -65.97%.

The current PE Ratio of CombiGene AB is ―. CombiGene AB’s PEG ratio is ―.

In the last 12 months, CombiGene AB had revenue of 326.00K and earned -44.88M in profits. Earnings per share was -2.27.

In the last 12 months, operating cash flow was -29.95M and capital expenditures 0.00, giving a free cash flow of -29.95M billion.

CombiGene AB pays an annual dividend of ―, resulting in a dividend yield of ―

CombiGene AB upcoming earnings date is Nov 7, 2025, TBA (Confirmed).

CombiGene AB as a current ratio of 17.47, with Debt / Equity ratio of 0.00%

In the past 12 months, CombiGene AB has paid 0.00 in taxes.

CombiGene AB EV to EBITDA ratio is 0.78, with an EV/FCF ratio of 0.89.

CombiGene AB has €73.75M in cash and marketable securities with €0.00 in debt, giving a net cash position of €73.75M billion.

Gross margin is -71.91%, with operating margin of -14484.05%, and net profit margin of -13766.26%.

The average price target for CombiGene AB is ―, which is 11.43% higher than the current price. The consensus rating is ―